Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 23Neutropenia 22Neoplasms 7Chemotherapy-induced Neutropenia 7Lymphoma, Non-Hodgkin 6Ovarian Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Triple Negative Breast Neoplasms 3Lymphoma 3Fever 3Febrile Neutropenia 3Colorectal Neoplasms 3Rectal Neoplasms 2Neoplasm Metastasis 2Lung Neoplasms 2Hodgkin Disease 2Fallopian Tube Neoplasms 2Colonic Neoplasms 2Carcinoma, Ovarian Epithelial 2Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1Prostatic Neoplasms 1Previously Treated Non Small Cell Lung Cancer 1Neuroectodermal Tumors, Primitive, Peripheral 1Malignant Solid Tumors 1Lymphoma, T-Cell, Peripheral 1Leukemia, Myeloid, Acute 1

Interventions

pegfilgrastim 1adavosertib 1Antimitotic Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Previously Treated Non Small Cell Lung Cancer × pegfilgrastim × Clear all
NCT02087176 2016-06-14

A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer

AstraZeneca

Phase 2 Terminated
48 enrolled 11 charts
Thoracic

Previously Treated Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡